CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
How did CLGN's recent EPS compare to expectations?
The most recent EPS for Collplant Biotechnologies Ltd is $, expectations of $-0.19.
How did Collplant Biotechnologies Ltd CLGN's revenue perform in the last quarter?
Collplant Biotechnologies Ltd revenue for the last quarter is $
What is the revenue estimate for Collplant Biotechnologies Ltd?
According to 4 of Wall street analyst, the revenue estimate of Collplant Biotechnologies Ltd range from $10.29M to $470.4K
What's the earning quality score for Collplant Biotechnologies Ltd?
Collplant Biotechnologies Ltd has a earning quality score of B/39.224514. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Collplant Biotechnologies Ltd report earnings?
Collplant Biotechnologies Ltd next earnings report is expected in 2026-08-27
What are Collplant Biotechnologies Ltd's expected earnings?
Collplant Biotechnologies Ltd expected earnings is $1.12M, according to wall-street analysts.
Did Collplant Biotechnologies Ltd beat earnings expectations?
Collplant Biotechnologies Ltd recent earnings of $ expectations.